150 related articles for article (PubMed ID: 38294612)
1. Race and Odds of Surgery Offer in Small Bowel and Pancreas Neuroendocrine Neoplasms.
Zarate Rodriguez JG; Raper L; Sanford DE; Trikalinos NA; Hammill CW
Ann Surg Oncol; 2024 May; 31(5):3249-3260. PubMed ID: 38294612
[TBL] [Abstract][Full Text] [Related]
2. Racial disparities in pancreatic neuroendocrine tumors survival: a SEER study.
Zhou H; Zhang Y; Wei X; Yang K; Tan W; Qiu Z; Li S; Chen Q; Song Y; Gao S
Cancer Med; 2017 Nov; 6(11):2745-2756. PubMed ID: 28980417
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Recurrence Between Pancreatic and Duodenal Neuroendocrine Neoplasms After Curative Resection: A Single-Institution Analysis.
Masui T; Sato A; Nakano K; Uchida Y; Yogo A; Anazawa T; Nagai K; Kawaguchi Y; Takaori K; Uemoto S
Ann Surg Oncol; 2018 Feb; 25(2):528-534. PubMed ID: 29164413
[TBL] [Abstract][Full Text] [Related]
4. Racial disparities in recommendations for surgical resection of primary brain tumours: a registry-based cohort analysis.
Butterfield JT; Golzarian S; Johnson R; Fellows E; Dhawan S; Chen CC; Marcotte EL; Venteicher AS
Lancet; 2022 Dec; 400(10368):2063-2073. PubMed ID: 36502844
[TBL] [Abstract][Full Text] [Related]
5. May we challenge the ENETS guidelines in pancreatic neuroendocrine neoplasms? A quiz for French experts.
Brieau B; Coriat R
Dig Liver Dis; 2017 Jul; 49(7):809-819. PubMed ID: 28377287
[TBL] [Abstract][Full Text] [Related]
6. Racial disparities in operative management of localized, non-functional pancreatic neuroendocrine tumors in surgically fit patients.
Bingmer KE; Hue JJ; Sugumar K; Ammori JB; Rothermel LD; Winter JM; Hardacre JM; Ocuin LM
HPB (Oxford); 2022 Feb; 24(2):217-225. PubMed ID: 34247942
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic resection: a key component to reducing racial disparities in pancreatic adenocarcinoma.
Murphy MM; Simons JP; Hill JS; McDade TP; Chau Ng S; Whalen GF; Shah SA; Harrison LH; Tseng JF
Cancer; 2009 Sep; 115(17):3979-90. PubMed ID: 19514091
[TBL] [Abstract][Full Text] [Related]
8. The Role of Perioperative Systemic Therapy in Localized Pancreatic Neuroendocrine Neoplasms.
Xie H; Liu J; Yadav S; Keutgen XM; Hobday TJ; Strosberg JR; Halfdanarson TR
Neuroendocrinology; 2020; 110(3-4):234-245. PubMed ID: 31121586
[TBL] [Abstract][Full Text] [Related]
9. Racial and ethnic disparities in surgery for kidney cancer: a SEER analysis, 2007-2014.
Balakrishnan A; Burdett KB; Kocherginsky M; Jordan N
Ethn Health; 2023 Nov; 28(8):1103-1114. PubMed ID: 37165613
[TBL] [Abstract][Full Text] [Related]
10. Operative resection in early stage pancreatic neuroendocrine tumors in the United States: Are we over- or undertreating patients?
Chivukula SV; Tierney JF; Hertl M; Poirier J; Keutgen XM
Surgery; 2020 Jan; 167(1):180-186. PubMed ID: 31537303
[TBL] [Abstract][Full Text] [Related]
11. Interaction of race and pathology for neuroendocrine tumors: Epidemiology, natural history, or racial disparity?
DePalo DK; Lee RM; Lopez-Aguiar AG; Gamboa AC; Rocha F; Poultsides G; Dillhoff M; Fields RC; Idrees K; Nathan H; Abbott D; Maithel SK; Russell MC;
J Surg Oncol; 2019 Nov; 120(6):919-925. PubMed ID: 31385621
[TBL] [Abstract][Full Text] [Related]
12. Surgical Principles in the Management of Pancreatic Neuroendocrine Neoplasms.
Andreasi V; Muffatti F; Guarneri G; Falconi M; Partelli S
Curr Treat Options Oncol; 2020 Apr; 21(6):48. PubMed ID: 32350693
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine Neoplasms: Identification of Novel Metabolic Circuits of Potential Diagnostic Utility.
Jiménez B; Abellona U MR; Drymousis P; Kyriakides M; Clift AK; Liu DSK; Rees E; Holmes E; Nicholson JK; Kinross JM; Frilling A
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33498434
[TBL] [Abstract][Full Text] [Related]
14. Racial differences in cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarcinoma.
Murphy MM; Simons JP; Ng SC; McDade TP; Smith JK; Shah SA; Zhou Z; Earle CC; Tseng JF
Ann Surg Oncol; 2009 Nov; 16(11):2968-77. PubMed ID: 19669839
[TBL] [Abstract][Full Text] [Related]
15. Racial Disparities and Trends in Pancreatic Cancer Incidence and Mortality in the United States.
Tavakkoli A; Singal AG; Waljee AK; Elmunzer BJ; Pruitt SL; McKey T; Rubenstein JH; Scheiman JM; Murphy CC
Clin Gastroenterol Hepatol; 2020 Jan; 18(1):171-178.e10. PubMed ID: 31202981
[TBL] [Abstract][Full Text] [Related]
16. Dissecting racial disparities in the treatment of patients with locoregional pancreatic cancer: a 2-step process.
Riall TS; Townsend CM; Kuo YF; Freeman JL; Goodwin JS
Cancer; 2010 Feb; 116(4):930-9. PubMed ID: 20052726
[TBL] [Abstract][Full Text] [Related]
17. Utility of contrast-enhanced harmonic endoscopic ultrasonography for predicting the prognosis of pancreatic neuroendocrine neoplasms.
Ishikawa R; Kamata K; Hara A; Tanaka H; Okamoto A; Yamazaki T; Nakai A; Omoto S; Minaga K; Yamao K; Takenaka M; Minami Y; Watanabe T; Chiba Y; Chikugo T; Matsumoto I; Takeyama Y; Matsukubo Y; Hyodo T; Kudo M
Dig Endosc; 2021 Jul; 33(5):829-839. PubMed ID: 33020955
[TBL] [Abstract][Full Text] [Related]
18. Outcomes after distal pancreatectomy for neuroendocrine neoplasms: a retrospective comparison between minimally invasive and open approach using propensity score weighting.
Partelli S; Andreasi V; Rancoita PMV; Perez-Sanchez E; Muffatti F; Balzano G; Crippa S; Di Serio C; Falconi M
Surg Endosc; 2021 Jan; 35(1):165-173. PubMed ID: 31953734
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological features and prognosis factors for survival in elderly patients with pancreatic neuroendocrine tumor: A STROBE-compliant article.
Li G; Tian ML; Bing YT; Tao LY; Wang HY; Jiang B; Yuan CH; Xiu DR
Medicine (Baltimore); 2019 Mar; 98(11):e14576. PubMed ID: 30882623
[TBL] [Abstract][Full Text] [Related]
20. Disparities in cancer outcomes across age, sex, and race/ethnicity among patients with pancreatic cancer.
Nipp R; Tramontano AC; Kong CY; Pandharipande P; Dowling EC; Schrag D; Hur C
Cancer Med; 2018 Feb; 7(2):525-535. PubMed ID: 29322643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
